|
The Wall Street Journal interviewed UNIVEC Sept. 28,1999 saying "Sales have risen from 745,000 in 1997 to a projeced 4.5 million in 1999. Its stock has gone from $10.13 to $0.18 per share, because on no visibilty". It is a GREAT company! Most states are mandating better syringes for health care workers and people that must use syringes (like diabetics) and yet the stock isn't being retailed. ANY QUESTIONS? I have read about the large percentage of death prevention with this product from diseases like HIV and Hepatitis C. Look at the stock it is just sitting there at affordable prices. |